國藝娛樂(08228.HK)折讓約6.54%發行1億股 淨籌約1985萬港元
格隆匯2月5日丨國藝娛樂(08228.HK)公佈,於2月4日,公司與認購人就認購事項訂立認購協議。
根據認購協議,公司按認購價每股認購股份0.200港元向認購人配發及發行1億股股份。認購股份將根據一般授權配發及發行。
公告顯示,假設公司已發行股本在認購協議日期至完成日期期間並無其他變動,認購股份相當於(i)於認購協議日期,公司現有已發行股本約2.02%;及(ii)經擴大已發行股本約1.98%。
據悉,認購價較報收市價每股0.214港元折讓約6.54%。
公告稱,所得款項淨額約1985萬港元。公司擬將所得款項淨額用作一般營運資金,支持其業務營運。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.